<p>Almost all postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive <a href="https://www.aacr.org/patients-caregivers/cancer/breast-cancer/">breast cancer</a> and low scores on a common genetic test who opted out of adjuvant rad…